Vectivbio Holding Ag (VECT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -93,735 | -87,009 | -59,943 | N/A | N/A |
| Depreciation Amortization | 239 | 303 | 270 | N/A | N/A |
| Accounts payable and accrued liabilities | -6,783 | -574 | 5,594 | N/A | N/A |
| Other Working Capital | 9,496 | 1,194 | 2,396 | N/A | N/A |
| Other Operating Activity | 34,524 | 13,947 | 13,471 | 0 | 0 |
| Operating Cash Flow | $-56,259 | $-72,139 | $-38,212 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -7 | N/A | N/A |
| PPE Investments | -74 | -57 | -93 | N/A | N/A |
| Net Acquisitions | N/A | -1,197 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -5,418 | 31 | 0 | 0 |
| Investing Cash Flow | $-74 | $-6,672 | $-69 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,660 | N/A | 2,931 | N/A | N/A |
| Common Stock Issued | 179,326 | 154,125 | 55,137 | N/A | N/A |
| Common Stock Repurchased | -5 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -13,925 | -12,798 | -1,481 | 0 | 0 |
| Financing Cash Flow | $175,056 | $141,327 | $56,587 | $N/A | $N/A |
| Exchange Rate Effect | -14 | 19 | 2,053 | N/A | N/A |
| Beginning Cash Position | 102,707 | 40,172 | 19,813 | N/A | N/A |
| End Cash Position | 221,416 | 102,707 | 40,172 | N/A | N/A |
| Net Cash Flow | $118,709 | $62,535 | $20,359 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,259 | -72,139 | -38,212 | N/A | N/A |
| Capital Expenditure | -74 | -57 | -93 | N/A | N/A |
| Free Cash Flow | -56,333 | -72,196 | -38,305 | 0 | 0 |